Welcome to YLOAN.COM
yloan.com » Health » Early HIV and Hepatitis C disease testing
Health Medical Acne Aerobics-Cardio Alternative Anti-Aging Build-Muscle Chronic-Illness Dental-Care Depression Diabetes Disability Exercise Eye-Care Fitness-Equipment Hair-Loss Medicine Meditation Nutrition Obesity Polution Quit-Smoking Sidha Supplements Yeast Infection H1N1 Swine Flu SARS herpes therapy panic surgeon hurts teeth remedies eliminate chiropractic arthritis ingredients syndrome binding anxiety surgery medication psychic dental reflux doctor relief premature emotional stress disorder implants wrinkles vision infection aging liposuction seattle stunning sweating hair treatment tinnitus

Early HIV and Hepatitis C disease testing

Early HIV and Hepatitis C disease testing


HIV/HBV/HCV Multiplex by PCR

HIV and Hepatitis C Early Detection Screen

Introducing real-time PCR testing to detect:

HIV type 1 (Groups M & O)

HIV type 2 (RNA)

Hepatitis B virus (HBV DNA)

Hepatitis C virus (HCV RNA)

in a single automated multiplex assay (simultaneous reporting). Nucleic acid amplification technologies (NAT) allow for more specific detection of active infections in blood earlier than conventional serology tests are able.

Early Detection of HIV by PCR at 10 days post exposure for HIV I/II and HCV and 24 days before detection of HBsAg by enzyme. Performance: The AMPLINAT MPX HIV and Hepatitis C testing assay has a diagnostic sensitivity of 99.8% and specificity of 99.85%.

Summary and explanation of the screening test

The Roche COBAS TaqScreen MPX Test is a qualitative multiplex test that enables simultaneous screening of HIV-1 Group M and Group O RNA, HIV-2 RNA, HCV RNA and HBV DNA in pooled and individual plasma donations. The cobas TaqScreen MPX Test does not discriminate which virus is detected in a specimen. Results are reported as either NOT DETECTED or DETECTED. Positive findings are immediately reflexed for individual CONFIRMATORY testing using the Roche COBAS AmpliScreen HIV-1 Test, v1.5, COBAS AmpliScreen HCV Test, v2.0 and COBAS AmpliScreen HBV Test for viral target identification (Discriminatory Testing) of HIV-1 Group M, HCV and HBV*, as follows:-

HIV = 20 HIV-1 RNA cp/ml to 1.00E+07 cp/ml

Hep C= 15 HCV RNA IU/ml to 6.90E+07 IU/ml

Hep B = 20 HBV DNA IU/ml to 1.70E+08 IU/ml

In addition, we are now able to add syphilis to the testing system looking for syphilis IgG and IgM.

A negative HIV and Hepatitis C early detection test at 7 days or more carries an overall accuracy of greater than 99.8%.
Hair Loss Causes and Herbal Remedies for Hair Loss Varicose veins Causes and Symptoms and Home Remedy Treatment for Varicose veins Herbal Treatments For Uterine Fibroids How to Maintain Colon Health with Oxy-Powder Obtaining A Healthier Lifestyle with The Smokeless Cigarette Identifying Truths In Electronic Cigarette Reviews Using Smoking Benefit To Find Electronic Cigarette Benefits How to get an ‘A' In Personal Wellness The Devilbiss Sleepcube Cpap: Competition For Market Leaders Resmed And Respironics Using BizTalk in Healthcare for HL7, HIPAA, EDI Integration Go Healthy, Wealthy and Wise with Kerala Ayurveda THE GREAT TRAIN ROBBERY - ROBS YOU OF SLEEP!! Omega 3 Fish Oil Capsules – Why This Supplement Is It Important For Our Body?
print
www.yloan.com guest:  register | login | search IP(216.73.216.146) California / Anaheim Processed in 0.016587 second(s), 5 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 32 , 1950, 61,
Early HIV and Hepatitis C disease testing Anaheim